Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon R Bernard

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
Critical Care Medicine|March 11, 2003
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trialJean-Louis Vincent, Derek C Angus, Antonio Artigas, et al.
JAMA|October 4, 2017
Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical TrialBen Andrews, Matthew W Semler, Levy Muchemwa, et al.
Critical Care Medicine|July 1, 2006
Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsisTodd W Rice, Arthur P Wheeler, Peter E Morris, et al.
Critical Care Medicine|January 23, 2008
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndromePeter E Morris, Peter Papadakos, James A Russell, et al.
Annals of Intensive Care|September 25, 2013
Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsisDavid R Janz, Zhiguo Zhao, Tatsuki Koyama, et al.
Critical Care Medicine|July 9, 2015
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill PatientsCiara M Shaver, Wei Chen, David R Janz, et al.
BMC Pulmonary Medicine|February 5, 2017
Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuriesDerek W Russell, David R Janz, William L Emerson, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 23, 2012
Clinical and translational research studios: a multidisciplinary internal support programDaniel W Byrne, Italo Biaggioni, Gordon R Bernard, et al.
Chest|June 11, 2004
Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsisGordon R Bernard, Benjamin D Margolis, Harvey M Shanies, et al.
Critical Care Medicine|January 11, 2005
The effect of drotrecogin alfa (activated) on long-term survival after severe sepsisDerek C Angus, Pierre-Francois Laterre, Jeff Helterbrand, et al.
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
Critical Care Medicine|March 11, 2003
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trialJean-Louis Vincent, Derek C Angus, Antonio Artigas, et al.
JAMA|October 4, 2017
Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical TrialBen Andrews, Matthew W Semler, Levy Muchemwa, et al.
Critical Care Medicine|July 1, 2006
Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsisTodd W Rice, Arthur P Wheeler, Peter E Morris, et al.
Critical Care Medicine|January 23, 2008
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndromePeter E Morris, Peter Papadakos, James A Russell, et al.
Annals of Intensive Care|September 25, 2013
Longer storage duration of red blood cells is associated with an increased risk of acute lung injury in patients with sepsisDavid R Janz, Zhiguo Zhao, Tatsuki Koyama, et al.
Critical Care Medicine|July 9, 2015
Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill PatientsCiara M Shaver, Wei Chen, David R Janz, et al.
BMC Pulmonary Medicine|February 5, 2017
Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuriesDerek W Russell, David R Janz, William L Emerson, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 23, 2012
Clinical and translational research studios: a multidisciplinary internal support programDaniel W Byrne, Italo Biaggioni, Gordon R Bernard, et al.
Chest|June 11, 2004
Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsisGordon R Bernard, Benjamin D Margolis, Harvey M Shanies, et al.
Critical Care Medicine|January 11, 2005
The effect of drotrecogin alfa (activated) on long-term survival after severe sepsisDerek C Angus, Pierre-Francois Laterre, Jeff Helterbrand, et al.
Pageof 23